Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector (AI) and Pre-Filled Syringe (PFS) of SB4 in Healthy Subjects

References

• GarrisonL, McDonnellND. Etanercept: therapeutic use in patients with rheumatoid arthritis. Ann Rheum Dis. 1999;58(Suppl 1):I65–9.10577976
   PubMed Web of Science ®Google Scholar
• Committee for Medicinal Products for Human Use (CHMP). Guideline on similar biological medicinal products containing monoclonal antibodies-non clinical and clinical issues. European Medicines Agency; 2012 Available from: http://www.ema.europa.eu/en/documents/scientific-guideline/guideline-similar-biological-medicinal-products-containing-monoclonal-antibodies-non-clinical_en.pdf. Accessed 510, 2019.
   Google Scholar
• Food and Drug Administration Center for Drug Evaluation and Research. Guidance for industry: scientific considerations in demonstrating biosimilarity to a reference product. U.S. Department of Health and Human Services; 2015 Available from: https://www.fda.gov/media/82647/download. Accessed 510, 2019.
   Google Scholar
• EmeryP, VencovskyJ, SylwestrzakA, et al. 52-week results of the Phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis. Rheumatology (Oxford). 2017;56(12):2093–2101. doi:10.1093/rheumatology/kex26928968793
   PubMed Web of Science ®Google Scholar
• EmeryP, VencovskyJ, SylwestrzakA, et al. Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4. Ann Rheum Dis. 2017;76:1986–1991. doi:10.1136/annrheumdis-2017-211591
   PubMed Web of Science ®Google Scholar
• LeeYJ, ShinD, KimY, et al. A randomized phase I pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel ®) in healthy subjects. Br J Clin Pharmacol. 2016;82(1):64–73. doi:10.1111/bcp.1292926972584
   PubMed Web of Science ®Google Scholar
• EmeryP, VencovskyJ, SylwestrzakA, et al. A Phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in pts with active RA. Ann Rheum Dis. 2017;76(1):51–57. doi:10.1136/annrheumdis-2015-20758826150601
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Benepali summary of product characteristics. Available from: https://www.ema.europa.eu/en/documents/product-information/benepali-epar-product-information_en.pdf. Accessed 821, 2019.
   Google Scholar
• U.S. Food & Drug Administration. Eticovo full prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf. Accessed 821, 2019.
   Google Scholar
• Borrás-BlascoJ, Gracia-PérezA, Rosique-RoblesJD, CasteráMD, AbadFJ. Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen. Expert Opin Biol Ther. 2010;10(3):301–307. doi:10.1517/1471259090353063320059372
   PubMed Web of Science ®Google Scholar
• MurageMJ, TongbramV, FeldmanSR, et al. Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systemic literature review. Patient Prefer Adherence. 2018;12:1483–1503. doi:10.2147/PPA.S16750830174415
   PubMed Web of Science ®Google Scholar
• SharpLA. A medical anthropologist’s view on posttransplant compliance: the underground economy of medical survival. Transplant Proc. 1999;31(4A):31S–33S. doi:10.1016/S0041-1345(99)00121-9
   PubMed Web of Science ®Google Scholar
• Van Dem BemtBJ, ZwikkerHE, Van den EndeCH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012;8(4):337–351. doi:10.1586/eci.12.2322607180
   PubMed Web of Science ®Google Scholar
• DiMetteoMR. Variations in patient’s adherence to medical recommendation: a quantitative review of 50 years of research. Med Care. 2004;42:200–209. doi:10.1097/01.mlr.0000114908.90348.f915076819
   PubMed Web of Science ®Google Scholar
• MohrDC, CoxD, EpsteinL, BoudewynA. Teaching patients to self-inject: pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medication. J Behav Ther Exp Psychiatry. 2002;33:39–47. doi:10.1016/S0005-7916(02)00011-312389798
   PubMed Web of Science ®Google Scholar
• MostafaNM, NaderAM, NoertersheuerP, et al. Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis. J Eur Acad Dermatol Venereol. 2017;31(3):490–497. doi:10.1111/jdv.1388427545848
   PubMed Web of Science ®Google Scholar
• WadeJR, ParkerG, KosuticG, et al. Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn’s disease. J Clin Pharmacol. 2015;55(8):866–874. doi:10.1002/jcph.v55.825735646
   PubMed Web of Science ®Google Scholar
• Enbrel® (etanercept). Full Prescribing Information. Thousand Oaks, CA: Immunex Corporation; 2016.
   Google Scholar
• KroonL. Overview of insulin delivery pen devices. J Am Pharm Assoc. 2003;49:e118–131. doi:10.1331/JAPhA.2009.08125
   Google Scholar
• McCoyEK, WrightBM. A review of insulin pen devices. Postgrad Med. 2010;122:81–88. doi:10.3810/pgm.2010.05.214520463417
   PubMed Web of Science ®Google Scholar
• PaulC, StalderJF, ThaçiD, et al. Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis. J Eur Acad Dermatol Venereol. 2012;26(4):448–455. doi:10.1111/jdv.2012.26.issue-421557778
   PubMed Web of Science ®Google Scholar
• EberhardtKB, FexE. Functional impairment and disability in early rheumatoid arthritis-development over 5 years. J Rheumatol. 1995;22:1037–1042.7674227
   PubMed Web of Science ®Google Scholar
• DurmusD, UzunerB, DurmazY, et al. Michigan hand outcomes questionnaire in rheumatoid arthritis patients: relationship with disease activity, quality of life, and hand grip strength. J Back Musculoskelet Rehabil. 2013;26(4):467–473. doi:10.3233/BMR-13040823948837
   PubMed Web of Science ®Google Scholar
• ThakurK, BibergerA, HandrichA, RezkMF. Patient perceptions and preferences of two etanercept autoinjectors for rheumatoid arthritis: findings from a patient survey in Europe. Rheumatol Ther. 2016;3(2):245–256. doi:10.1007/s40744-016-0048-927817152
   PubMed Web of Science ®Google Scholar
• EgethM, SoosarJ, NashP, et al. Patient and healthcare professional’s preference for Brenzys vs. Enbrel autoinjector for rheumatoid arthritis: a randomized crossover simulated-use study. Adv Ther. 2017;34(5):1157–1172. doi:10.1007/s12325-017-0523-x28417318
   PubMed Web of Science ®Google Scholar